HYPERTROPHIC CARDIOMYOPATHY
Clinical trials for HYPERTROPHIC CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new HYPERTROPHIC CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for HYPERTROPHIC CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart drug shows promise for genetic heart condition
Disease control OngoingThis study is testing an experimental drug called EDG-7500 in 100 adults with hypertrophic cardiomyopathy (HCM), a genetic condition where the heart muscle thickens and can cause serious symptoms. Researchers want to understand if different doses are safe and how they affect hear…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE2 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Major trial seeks first treatment to slow genetic heart disease
Disease control OngoingThis study is testing if a medication called empagliflozin can help people with hypertrophic cardiomyopathy (HCM), a genetic condition that thickens the heart muscle and can lead to heart failure. For 12 months, 250 adult patients without diabetes will take either the drug or a p…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE3 • Sponsor: National Institute of Cardiology, Warsaw, Poland • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Smartwatch AI could spot hidden heart danger
Diagnosis OngoingThis study is testing whether artificial intelligence (AI) can accurately detect a serious heart condition called hypertrophic cardiomyopathy (HCM) using ECG readings from consumer devices like the Apple Watch and KardiaMobile. Researchers are comparing the AI's performance on th…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Mar 30, 2026 14:28 UTC
-
Doctors track hidden heart rhythms to uncover sleep apnea link
Knowledge-focused OngoingThis Mayo Clinic study aims to learn more about irregular heart rhythms in adults with hypertrophic cardiomyopathy, a condition where the heart muscle thickens. Researchers are observing 260 participants using a small implanted heart monitor to track rhythm patterns over time. A …
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:29 UTC